Michael F Kanan - Net Worth and Insider Trading
Michael F Kanan Net Worth
The estimated net worth of Michael F Kanan is at least $2 Million dollars as of 2024-04-23. Michael F Kanan is the VP & Corporate Controller of Sigma-Aldrich Corp and owns about 7,700 shares of Sigma-Aldrich Corp (SIAL) stock worth over $1 Million. Michael F Kanan is also the See Remarks of Avadel Pharmaceuticals PLC and owns about 29,538 shares of Avadel Pharmaceuticals PLC (AVDL) stock worth over $511,007. Details can be seen in Michael F Kanan's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Michael F Kanan has not made any transactions after 2018-12-14 and currently still holds the listed stock(s).
Transaction Summary of Michael F Kanan
Michael F Kanan Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael F Kanan owns 1 companies in total, including Avadel Pharmaceuticals PLC (AVDL) .
Click here to see the complete history of Michael F Kanan’s form 4 insider trades.
Insider Ownership Summary of Michael F Kanan
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AVDL | Avadel Pharmaceuticals PLC | 2018-12-14 | See Remarks |
Michael F Kanan Latest Holdings Summary
Michael F Kanan currently owns a total of 2 stocks. Among these stocks, Michael F Kanan owns 7,700 shares of Sigma-Aldrich Corp (SIAL) as of August 7, 2015, with a value of $1 Million and a weighting of 67.8%. Michael F Kanan also owns 29,538 shares of Avadel Pharmaceuticals PLC (AVDL) as of December 14, 2018, with a value of $511,007 and a weighting of 32.2%.
Latest Holdings of Michael F Kanan
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SIAL | Sigma-Aldrich Corp | 2015-08-07 | 7,700 | 139.76 | 1,076,152 |
| AVDL | Avadel Pharmaceuticals PLC | 2018-12-14 | 29,538 | 17.30 | 511,007 |
Holding Weightings of Michael F Kanan
Michael F Kanan Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael F Kanan has made a total of 0 transactions in Sigma-Aldrich Corp (SIAL) over the past 5 years. The most-recent trade in Sigma-Aldrich Corp is the sale of 9,832 shares on August 7, 2015, which brought Michael F Kanan around $1 Million.
According to the SEC Form 4 filings, Michael F Kanan has made a total of 0 transactions in Avadel Pharmaceuticals PLC (AVDL) over the past 5 years. The most-recent trade in Avadel Pharmaceuticals PLC is the sale of 8,429 shares on December 14, 2018, which brought Michael F Kanan around $20,988.
Insider Trading History of Michael F Kanan
- 1
Michael F Kanan Trading Performance
GuruFocus tracks the stock performance after each of Michael F Kanan's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michael F Kanan is -2.05%. GuruFocus also compares Michael F Kanan's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michael F Kanan within 3 months outperforms 2 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Michael F Kanan's insider trading performs compared to the benchmark.
Performance of Michael F Kanan
Average Return
2.07%
Outperforming Transactions
80%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 2.54 | -2.05 | -4.93 | 2.07 | 16.48 | 18.67 |
| Relative Return to S&P 500(%) | 2.33 | -6.51 | -13.06 | -12.82 | 2.36 | 2.51 |
Michael F Kanan Ownership Network
Ownership Network List of Michael F Kanan
Ownership Network Relation of Michael F Kanan
Michael F Kanan Owned Company Details
What does Avadel Pharmaceuticals PLC do?
Who are the key executives at Avadel Pharmaceuticals PLC?
Michael F Kanan is the See Remarks of Avadel Pharmaceuticals PLC. Other key executives at Avadel Pharmaceuticals PLC include Chief Financial Officer Thomas S Mchugh , director & Chief Executive Officer Greg J Divis , and Chief Commercial Officer Richard J Kim .
Avadel Pharmaceuticals PLC (AVDL) Insider Trades Summary
Over the past 18 months, Michael F Kanan made no insider transaction in Avadel Pharmaceuticals PLC (AVDL). Other recent insider transactions involving Avadel Pharmaceuticals PLC (AVDL) include a net purchase of 9,000 shares made by Thomas S Mchugh , a net sale of 103,975 shares made by Mark Anthony Mccamish , and a net purchase of 33,000 shares made by Eric J Ende .
In summary, during the past 3 months, insiders sold 0 shares of Avadel Pharmaceuticals PLC (AVDL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 103,975 shares of Avadel Pharmaceuticals PLC (AVDL) were sold and 70,500 shares were bought by its insiders, resulting in a net sale of 33,475 shares.
Avadel Pharmaceuticals PLC (AVDL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Avadel Pharmaceuticals PLC Insider Transactions
Michael F Kanan Mailing Address
Above is the net worth, insider trading, and ownership report for Michael F Kanan. You might contact Michael F Kanan via mailing address: 10-1 Blanchardstown Corporate Park, Ballycoolin, Dublin L2 15.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
